IRIS
ROMANO, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.816
EU - Europa 2.734
AS - Asia 1.106
SA - Sud America 18
Continente sconosciuto - Info sul continente non disponibili 12
AF - Africa 9
OC - Oceania 3
Totale 6.698
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.802
IT - Italia 520
CN - Cina 479
IE - Irlanda 467
UA - Ucraina 450
SE - Svezia 375
GB - Regno Unito 346
TR - Turchia 343
FR - Francia 263
IN - India 220
DE - Germania 152
FI - Finlandia 80
AT - Austria 23
VN - Vietnam 22
BE - Belgio 14
HK - Hong Kong 14
PE - Perù 13
CA - Canada 12
EU - Europa 11
PL - Polonia 11
IR - Iran 9
EG - Egitto 8
NL - Olanda 7
RU - Federazione Russa 6
IL - Israele 4
KR - Corea 4
RO - Romania 4
CL - Cile 3
ES - Italia 3
RS - Serbia 3
TW - Taiwan 3
AU - Australia 2
JP - Giappone 2
PH - Filippine 2
PT - Portogallo 2
SG - Singapore 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BR - Brasile 1
CZ - Repubblica Ceca 1
HR - Croazia 1
MD - Moldavia 1
ME - Montenegro 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 6.698
Salva come PNG Salva come JPEG
Città #
Chandler 666
Jacksonville 516
Dublin 461
Southend 268
Princeton 207
Izmir 201
Nanjing 132
Dearborn 112
Ashburn 108
Chieti 98
Altamura 90
Wilmington 88
Beijing 87
New York 81
Cambridge 80
Ann Arbor 73
Nanchang 63
Boardman 57
Rome 40
Montesilvano 34
San Mateo 29
Hebei 24
Washington 24
Woodbridge 24
Vienna 23
Dong Ket 22
Shenyang 22
Jiaxing 21
Kunming 21
Tianjin 21
Falls Church 20
Düsseldorf 19
Augusta 18
Houston 16
Brussels 14
Cornaredo 14
Grevenbroich 14
Central 12
Changsha 12
Toronto 11
Milan 10
Orange 10
San Buono 10
Seattle 10
Cairo 8
Hangzhou 8
Ica 8
Jinan 8
Lanzhou 7
Leawood 7
Meylan 7
Norwalk 7
Pescara 7
Piotrkow Trybunalski 7
Los Angeles 6
Tappahannock 6
Changchun 5
Fuzhou 5
Hefei 5
Lanciano 5
Lima 5
London 5
Redwood City 5
Saint-prix 5
Vasto 5
Ardabil 4
Auburn Hills 4
Chengdu 4
Haikou 4
Helsinki 4
Napoli 4
Ningbo 4
Rochester 4
Saint-Saens 4
Alessandria 3
Assergi 3
Belgrade 3
Casalbordino 3
Dacun 3
Edinburgh 3
Frankfurt Am Main 3
Guangzhou 3
Paris 3
Prato 3
Pune 3
Shanghai 3
Taizhou 3
Woburn 3
Amsterdam 2
Andover 2
Aprilia 2
Brezovica pri Ljubljani 2
Carpenedolo 2
Catania 2
Chicago 2
Delhi 2
Denver 2
Grafing 2
Grottaglie 2
Iesi 2
Totale 4.116
Salva come PNG Salva come JPEG
Nome #
Sistema di rilascio della lipossina A4 mediante membrana polimerica porosa ottenuta con elettrofilatura 184
Wnt Signaling Behaves as a "Master Regulator" in the Osteogenic and Adipogenic Commitment of Human Amniotic Fluid Mesenchymal Stem Cells 127
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 119
Mechanisms of endothelial cell dysfunction in cystic fibrosis 116
Molecular and phenotypic characterization of human amniotic fluid-derived cells: A morphological and proteomic approach 116
Lipoxin A4 stimulates endothelial miR-126-5p expression and its transfer via microvesicles 114
Screening tool for anti-inflammatory drug discovery comprising the FPR2/ALX gene promoter 113
Pentraxin 3 and platelet activation in obese patients after gastric banding 103
ASSOCIATION OF LEPTIN, ENDOTHELIAL PERTURBATION AND COAGULATIVE ACTIVATION IN OBESE HEALTHY WOMEN (XVI National Congress of the Italian Society for the study of Arteriosclerosis - Chieti, 27-30 novembre 2002) 102
Establishment and long-term culture of human cystic fibrosis endothelial cells 100
Impiego di cellule staminali da legamento parodontale per lo screening farmacologico in fibrosi cistica. 95
MicroRNA-181b regulates ALX/FPR2 expression and proresolution signaling in human macrophages. 93
Lipoxins, resolvins, and the resolution of inflammation 91
Endothelial Perturbation in Children andAdolescents With Type 1 Diabetes: association with markers of the inflammatory reaction 91
Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity 86
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 86
Physical exercise increases urinary excretion of lipoxin A4 and related compounds 82
Calcium Sensing Receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: Correlation with osteogenic differentiation. 81
microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense. 81
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 80
Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins 79
Urinary excretion of lipoxin A4 and related compounds: Development of new extraction techniques for lipoxins 79
Immobilization and delivery of biologically active Lipoxin A4 using electrospinning technology 79
Transcellular regulation of eicosanoids biosyntesis 78
Association of Inflammation Markers with ImpairedInsulin Sensitivity and Coagulative Activation inObese Healthy Women 77
Activation of human monocytes and the acute monocytic cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 and lipoxin B4: evidence for differential Ca2+ mobilization 75
Diabetes mellitus during pregnancy interferes with the biological characteristics of wharton's jelly mesenchymal stem cells 75
G972R IRS-1 variant impairs insulin regulation of eNOS in cultured human endothelial cells 74
Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels 73
Platelet-derived mitogenic activity and bone marrow fibrosis in myeloproliferative disorders 73
Leptin increase is associated with markers of the hemostatic system in obese healthy women 73
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 73
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 73
Increased soluble CD40L levels in cystic fibrosis 72
Lipoxin receptors 71
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 70
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 70
Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancer 69
Induction of functional Lipoxin A4 receptors in HL-60 cells 69
Homocysteine modulates the CD40/CD40L system 69
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors 69
5-Lipoxygenase regulates malignant mesothelial cellsurvival: involvement of vascular endothelialgrowth factor 69
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 69
Reduced platelet mitogenic activity in myeloproliferative disorders 68
Increased levels of soluble P-selectin in hypercholesterolemic patients 68
The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R 67
Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress 67
Lipoxin biosynthesis and actions: role of the human platelet LX-Synthase 66
Hepatocytes are a rich source of novel aspirin-trigged 15-epi-lipoxin A(4) 66
Ultrarush venom immunotherapy and the lipoxin a4 inflammation resolution pathway 66
Proteomics investigation of human platelets in healthy donors and cystic fibrosis patients by shotgun nUPLC-MSE and 2DE: a comparative study 65
Epigenetic regulation of the formyl peptide receptor 2 gene 65
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 65
Cyclooxygenase-2 and 5-Lipoxygenase converging functions on cell proliferation and tumor angiogenesis: Implications for cancer therapy 64
Lipoxin synthase activity of human platelet 12-Lipoxygenase 63
Cyclooxygenase-2-derived lipoxin A(4) increases gastric resistance to aspirin-induced damage 63
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction 63
Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipoxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin 63
Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review 63
Methionine aminopeptidase-2 regulates human mesothelioma cell survival - Role of bcl-2 expression and telomerase activity 63
Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen 62
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 62
Lipoxins and aspirin-triggered lipoxins in resolution of inflammation 62
Interaction of endotoxic lipid A and lipid X with purified human platelet protein kinase C 61
PRORESOLVING AND ANTIMICROBIAL BIOACTIONS OF MELANOCORTINS ON CF CELLS 61
Lipoxin generation by permeabilized human platelets 60
Peptido-leukotrienes stimulate von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells 59
Increased circulating Interleukin-18 levels in centenarians with no signs of vascular disease: Another paradox of longevity? 59
Inflammation resolution: does the bone marrow have a say? 59
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 59
Screening tool for anti-inflammatory drug discovery comprising the FPR2/ALX gene promoter 59
Human alveolar macrophages generate 15-HETE and can produce lipoxins 58
Ligand bias and its association with pro-resolving actions of melanocortin drugs 58
5-Lipoxygenase antagonizes genotoxic stress-induced apoptosis by altering p53 nuclear trafficking 58
Lipoxin generation by human magakaryocyte-induced 12-lipoxygenase 57
Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages. 57
Fluticasone propionate reduces serum interleukin 8 in asthmatic patients 56
Endothelial perturbation in cystic fibrosis. 56
Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide 56
Proteomics investigation of human platelets by shotgun nUPLC-MSE and 2DE experimental strategies: a comparative study 56
Lipoxin and leukotriene production during receptor-activated interactions between human platelets and cytokine-primed neutrophils 56
Myelofibrosis: A role for Platelet Derived Growth Factor (PDGF) ? 55
Aspirin-triggered 15-epi-lipoxin A4 biosynthesis in rat liver cells 55
Lipoxin analogs and lipoxin formation in vivo 55
Lipoxin and aspirin-triggered lipoxins 54
Endotoxic Lipid A induces intracellular Ca2+ increase in human platelets 52
PROTECTIVE ROLE OF RVD1 AND ITS RECEPTOR IN CYSTIC FIBROSIS 51
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 51
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 51
NEW GENETIC AND PHARMACOLOGICAL TREATMENTS FOR CYSTIC FIBROSIS 49
Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa 48
Lower platelet count in centenarians correlates with dispersion of the Q-T interval 48
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 48
Microvascular and Macrovascular Endothelial Cell Isolation and Purification from Lung-Derived Samples 43
Lipid mediators: lipoxin and aspirin-triggered 15-epi-lipoxins 43
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages 39
Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease. 38
The Resolution Approach to Cystic Fibrosis Inflammation 37
CFTR Modulation Reduces SARS-CoV-2 Infection in Human Bronchial Epithelial Cells 37
Type-4 Phosphodiesterase (PDE4) Blockade Reduces NETosis in Cystic Fibrosis 33
Totale 6.961
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.247
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.247
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019240 0 0 0 0 0 0 0 0 0 8 9 223
2019/20201.224 360 78 5 64 88 68 152 116 33 132 121 7
2020/2021807 102 10 104 27 64 126 54 18 124 104 28 46
2021/2022600 9 14 4 145 26 16 10 39 38 39 81 179
2022/20231.804 130 246 111 213 183 327 86 144 234 26 50 54
2023/2024833 78 46 49 30 57 294 185 51 19 24 0 0
Totale 7.091